Stockscreener 앱 받기
7.26
11.89%
-0.98
시장 영업 전:
7.22
-0.04
-0.55%
Eikon Therapeutics Inc 주식(EIKN)의 최신 뉴스
Atrium Therapeutics, Inc. (RNA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress - GlobeNewswire Inc.
Iambic Announces Pricing of Initial Public Offering - Yahoo Finance
A passive holder reports voting power over 5.52M shares in Eikon Therapeutics (EIKN). - Stock Titan
A subsidiary holds the shares behind Abu Dhabi Investment Authority’s Eikon Therapeutics (EIKN) stake. - stocktitan.net
Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering - Yahoo Finance
Dear Future Electra Therapeutics Stock Fans, Mark Your Calendars for Sept. 18 - Yahoo Finance
Eikon Therapeutics at Cantor conference: selective cancer drugs advance By Investing.com - Investing.com India
Eikon Therapeutics at Cantor conference: selective cancer drugs advance By Investing.com - Investing.com Canada
Eikon Therapeutics at Cantor conference: selective cancer drugs advance By Investing.com - Investing.com UK
Inhibrx stock, Eikon stock rise on insider buying (INBX:NASDAQ) - Seeking Alpha
Eikon Therapeutics (NASDAQ:EIKN) Trading Up 6.9% After Insider Buying Activity - MarketBeat
Eikon Therapeutics (NASDAQ:EIKN) Raised to Strong-Buy at Mizuho - MarketBeat
Group Iv Gp Lp Column Buys 89,200 Shares of Eikon Therapeutics (NASDAQ:EIKN) Stock - MarketBeat
Open-market insider buy at Eikon Therapeutics (EIKN) - Stock Titan
Eikon Therapeutics names CP Chang as chief scientific officer By Investing.com - Investing.com South Africa
Eikon Therapeutics names CP Chang as chief scientific officer By Investing.com - Investing.com Nigeria
Eikon Therapeutics names CP Chang as chief scientific officer By Investing.com - Investing.com Canada
Eikon Therapeutics Appoints CP Chang as Executive Vice President and Chief Scientific Officer - Quiver Quantitative
Eikon Therapeutics names CP Chang as chief scientific officer By Investing.com - Investing.com UK
Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer - finance.yahoo.com
A Bristol Myers Squibb research leader joins Eikon as science chief - Stock Titan
BlackRock Inc. Buys 962,046 Shares of Eikon Therapeutics, Inc. $EIKN - MarketBeat
EDGAR Filing Documents for 0001193125-26-349936 - sec.gov
Eikon Therapeutics to Participate in Investor Conferences in September 2026 - The Manila Times
Eikon Therapeutics to Participate in Investor Conferences in September 2026 - Moomoo
Eikon (EIKN) Financial Update: EPS Misses Its Estimate on the Day; After Results: The Stock Ends Up 12.46% in the Latest SessionProfit Announcement - vinanet.vn
Eikon Therapeutics, Inc. (NASDAQ:EIKN) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Eikon Therapeutics Eyes Safer PARP1 Cancer Treatments With EIK1003, EIK1004 - Yahoo Finance
Cantor Fitzgerald reiterates Overweight on Eikon stock - Investing.com
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald - Sahm
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald - The Manila Times
An oncology expert will discuss PARP drugs in four cancers Aug. 20 - Stock Titan
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald - Yahoo Finance
EIKN Q1 2026 Earnings: Deeper-than-Expected Loss but Shares Rally 6.97%Energy Earnings Report - vinanet.vn
Morgan Stanley Maintains Eikon Therapeutics(EIKN.US) With Buy Rating, Maintains Target Price $32 - Moomoo
$Eikon Therapeutics (EIKN.US)$ - Moomoo
Eikon Therapeutics adds Merck chemistry head to advisory board By Investing.com - Investing.com Nigeria
Form 8K EIKON THERAPEUTICS For: 14 August By Investing.com - Investing.com Australia
Eikon Therapeutics Updates Corporate Presentation, Files Form 8-K Under Regulation FD - kalkinemedia.com
Eikon Therapeutics, Inc. Stock 12‑Month Price Target Cut to $24.6, Implies 138% Upside - TradingView
Possible Turnaround For Eikon Therapeutics Insiders, Still Down US$852k - simplywall.st
Possible Turnaround For Eikon Therapeutics Insiders, Still Down US$852k - simplywall.st
Form 8K EIKON THERAPEUTICS For: 14 August By Investing.com - Investing.com Nigeria
Form 8K EIKON THERAPEUTICS For: 14 August By Investing.com - Investing.com Canada
Form 8K EIKON THERAPEUTICS For: 14 August By Investing.com - Investing.com India
Form 8K EIKON THERAPEUTICS For: 14 August By Investing.com - Investing.com UK
Eikon Therapeutics, Inc. Announces Appointment of Ma. Fatima D. Francisco as Independent Director and to the Compensation Committee - marketscreener.com
Eikon Therapeutics, Inc. 2Q 2026: Net income $(88.4)M, EPS $(1.63) — 10-Q Summary - TradingView
Eikon Therapeutics (EIKN) reports $171.4M first-half loss and $531M cash - Stock Titan
3.09%
0.72%
자본화:
|
볼륨(24시간):